1. Home
  2. ARTL vs NXAT Comparison

ARTL vs NXAT Comparison

Compare ARTL & NXAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

N/A

Current Price

$1.45

Market Cap

1.4M

Sector

Health Care

ML Signal

N/A

Logo Nexus Advanced Technologies Inc. Ordinary Shares

NXAT

Nexus Advanced Technologies Inc. Ordinary Shares

N/A

Current Price

$0.22

Market Cap

1.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
ARTL
NXAT
Founded
2011
2023
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.4M
1.2M
IPO Year
2014
2023

Fundamental Metrics

Financial Performance
Metric
ARTL
NXAT
Price
$1.45
$0.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
27.2K
★ 148.6K
Earning Date
11-12-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.52
$0.30
52 Week High
$179.19
$1.23

Technical Indicators

Market Signals
Indicator
ARTL
NXAT
Relative Strength Index (RSI) 26.43 23.41
Support Level $0.52 N/A
Resistance Level $6.81 $0.53
Average True Range (ATR) 0.25 0.07
MACD 0.00 0.00
Stochastic Oscillator 0.00 2.18

Price Performance

Historical Comparison
ARTL
NXAT

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About NXAT Nexus Advanced Technologies Inc. Ordinary Shares

Nexus Advanced Technologies Inc pursuing strategic investments, acquisitions, and partnerships across AI infrastructure and technologies. The Company's ideas include opportunities involving data centers, AI compute and GPU infrastructure, and other technologies supporting the development and deployment of artificial intelligence. Nexus seeks to combine access to capital, strategic partnerships, and technology opportunities to build a diversified platform positioned to participate in the continued growth of world-wide AI infrastructure.

Share on Social Networks: